Skip to main content

Table 4 Multivariate analysis for the end point (all-cause mortality)

From: Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy

 

Univariate analysis

Multivariate analysisa)

HR

95% CI

P-value

HR

95% CI

P-value

Male

2.6

1.2–5.7

0.01

1.8

0.8–4.0

0.14

EF ≤ 35%

4.8

2.2–104

< 0.01

3.6

1.6–8.1

< 0.01

Emotionalerstress

0.4

0.1–1.1

0.10

   

Inotropic drugs

3.9

1.9–7.9

< 0.01

2.2

1.0–4.8

0.04

Diabetes mellitus Typ II

1.0

0.7–1.4

0.81

   

Hypertension

0.9

0.7–1.2

0.64

   

Apical ballooning

1.1

0.8–1.4

0.39

   

History of cancer

1.7

0.7–4.2

0.21

   

Smoking

0.7

0.3–1.6

0.49

   
  1. HR hazard ratio, EF ejection fraction, CRP c-reactive protein, GFR glomerular filtration rate
  2. aOnly the following variables with significant effects in univariate analysis were analyzed by multivariate Cox regression: Male, EF ≤ 35%, Inotropic drugs
  3. The bolded indication highlight significant values
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us